Page 96 | Certara

Case Study

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Agent-based models focus on the heterogeneous behavior of individual agents and their interactions with one…

CertaraMarch 2, 2023

Press Coverage

Advancing data discovery in the life sciences through artificial intelligence

Vyasa has developed deep-learning artificial intelligence solutions for organizations looking to solve the complex data…

CertaraMarch 2, 2023

Video

Vyasa Demo

CertaraMarch 2, 2023

Press Release

Certara Announces Transition Plan For Chief Financial Officer

PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…

CertaraMarch 1, 2023

On-Demand Webinar

Learn how to create CDISC domains in minutes with PK Submit

Creating CDISC domains as part of the pharmacokinetic (PK) deliverable for regulatory submissions can be…

CertaraMarch 1, 2023

White Paper

Understanding Europe’s New Clinical Trial Regulations (EU-CTR)

While the new EU-CTR will help to streamline clinical trials, which will benefit both patients…

CertaraFebruary 27, 2023

Blog

Common Clinical Trial Disclosure Challenges & Potential Solutions

Pharmaceutical companies are being required to be more transparent through the timely disclosure of more…

CertaraFebruary 24, 2023

On-Demand Webinar

FDA Modernization Act 2.0 – What does it mean for drug developers?

Historically, the FDA has required drug discovery and development programs to include animal testing. This…

CertaraFebruary 21, 2023

Conference

Lab of the Future USA

Conference: Lab of the Future USA Date: March 10-11, 2025 Location: Boston, MA Presenters: Nick…

CertaraFebruary 15, 2023

Conference

Asembia AXS25 Summit

April 27-May 1, 2025 - Las Vegas, Nevada - Booth #1523

CertaraFebruary 15, 2023

Agent-Based Model Predicts Impact of Monoclonal Antibody Treatment, Prophylaxis & Vaccines on Viral Transmission during Pandemic

Advancing data discovery in the life sciences through artificial intelligence

Vyasa Demo

Certara Announces Transition Plan For Chief Financial Officer

Learn how to create CDISC domains in minutes with PK Submit

Understanding Europe’s New Clinical Trial Regulations (EU-CTR)

Common Clinical Trial Disclosure Challenges & Potential Solutions

FDA Modernization Act 2.0 – What does it mean for drug developers?

Lab of the Future USA

Asembia AXS25 Summit

Newsletter sign up

Quick links

Solutions

Contact